Did you know? 🚨 NHS waiting lists have nearly tripled over the past decade, skyrocketing to a staggering 7.4 million for patients in England alone! 😱 This has caused major challenges in driving patient access to medicines for pharmaceutical companies across the UK. 💊 Apodi has explored these issues, offering invaluable insights on how pharmaceutical companies can support the NHS in tackling these waiting lists, while ensuring better access to essential medications. 💪 Curious about our findings and how we're making a difference? Dive into our case study for a closer look at how collaboration can pave the way for better healthcare outcomes: https://lnkd.in/edpKraa9 📈💡 #Healthcare #PatientAccess #PatientCare #PatientExperience #PatientCentricity #PatientSupport #Homecare #PSP #NHS
Apodi Limited’s Post
More Relevant Posts
-
Did you know? 🚨 NHS waiting lists have nearly tripled over the past decade, skyrocketing to a staggering 7.4 million for patients in England alone! 😱 This has caused major challenges in driving patient access to medicines for pharmaceutical companies across the UK. 💊 Apodi has explored these issues, offering invaluable insights on how pharmaceutical companies can support the NHS in tackling these waiting lists, while ensuring better access to essential medications. 💪 Curious about our findings and how we're making a difference? Dive into our case study for a closer look at how collaboration can pave the way for better healthcare outcomes: https://lnkd.in/edpKraa9 📈💡 #Healthcare #PatientAccess #PatientCare #PatientExperience #PatientCentricity #PatientSupport #Homecare #PSP #NHS
-
-
Did you know? 🚨 NHS waiting lists have nearly tripled over the past decade, skyrocketing to a staggering 7.4 million patients in England alone! 😱 This surge has posed significant challenges for pharmaceutical companies in ensuring patient access to medicines across the UK. 💊 Apodi has explored these issues, offering invaluable insights on how pharmaceutical companies can support the NHS in tackling these waiting lists, while ensuring better access to essential medications. 💪 Curious about our findings and how we’re making a difference? 🤔 Dive into our case study for a closer look at how collaboration can pave the way for better healthcare outcomes, here 👉 https://lnkd.in/edpKraa9 #Healthcare #PatientAccess #PatientCare #PatientExperience #PatientCentricity #PatientSupport #Homecare #PSP #NHS
-
-
Did you know? 🚨 NHS waiting lists have nearly tripled over the past decade, reaching a staggering 7.4 million patients in England alone! 😱 This surge has created significant challenges for pharmaceutical companies in ensuring patient access to medicines across the UK. 💊 At Apodi, we’ve delved into these issues and provided invaluable insights on how pharmaceutical companies can support the NHS in addressing these waiting lists, while improving access to essential medications. ⚕️ Curious about our findings and how we’re making a difference? Dive into our case study here 👉 https://lnkd.in/edpKraa9 #Healthcare #PatientAccess #PatientCare #PatientExperience #PatientCentricity #PatientSupport #Homecare #PSP #NHS
-
-
As we continue the conversation around the importance of quality medicine for patient safety, we’re glad to feature Sudarshan Jain, General Secretary of the Indian Pharmaceutical Alliance sharing his perspective on the power of collaboration in safeguarding patient health, how #scheduleM has been pivotal in guiding the Indian pharmaceutical industry's commitment to providing quality medicines for patients worldwide. Watch the video to learn more about how collaboration and adherence to quality standards are transforming patient safety in the global healthcare landscape.
-
Catch up on our regular column - Value Viewpoint - where Kimberly Westrich (Chief Strategy Officer, National Pharmaceutical Council) shares highlights on US healthcare value and access from May and June 2024. Read at The Evidence Base® #heor #healtheconomics #marketaccess #medicalaffairs #hta #healthtechnologyassessment #healthdata #healthpolicy #valueassessment #inflationreductionact #ISPORAnnual
-
Strategic Corporate Communications Executive | Award-Winning Reputation Management and Media Relations Expert | Specializes in Media Outreach, Crisis Management, and Brand Elevation for Highly Regulated Industries
🚨 A House Oversight report finds that Pharmacy Benefit Managers (PBMs) prioritize higher-priced medicines when lower-cost options are available for patients - leading to higher costs for patients and the healthcare system. Combined with today's hearing on accountability and transparency for PBMs, this report marks a significant moment in time for drug manufacturers to illustrate how patients benefit from the medicines they develop. 💊 The pharmaceutical industry has an opportunity to lift patient stories to highlight the real-world personal impact of their products in the media, on social media, and through digital promotion. Patient stories resonate emotionally with audiences, fostering empathy and understanding while emphasizing the significance of innovation in healthcare. By sharing authentic narratives, patients can effectively convey the benefits of treatments. Companies should highlight medical advancements and demonstrate their commitment to these patients. https://lnkd.in/gnDm2wUn
Exclusive | Drug Middlemen Push Patients to Pricier Medicines, House Probe Finds
wsj.com
-
This just in: We’ve updated our Guiding Practices for Patient-Centered Value Assessment! The Guiding Practices include 33 specific recommendations to ensure value assessments account for the full value pharmaceuticals provide to patients and society. Access the 2024 edition here: https://lnkd.in/eespYnVy
NPC's 2024 Guiding Practices for Patient-Centered Value Assessment
npcnow.org
-
Did you know? 💡 Transforming homecare services can significantly enhance patient care and boost ROI for pharmaceutical companies. 🚀 Whilst pharmaceutical companies have long provided valuable homecare services for patients and the NHS, true transformation requires differentiation. 🏥 Apodi’s homecare service is therefore designed to make a real difference – transforming patient care and supporting the NHS. 👩⚕️ Our focus on operational excellence ensures faster care delivery, in addition to our offering of personalised care plans and a patient portal for tailored support. ⏱️ To learn more about Apodi’s strategy for delivering integrated homecare services, watch the video below, or click here 👉 https://lnkd.in/eGWCU5DU #Homecare #Healthcare #PatientCare #PatientSafety #PatientExperience #PatientCentricity #Patients #NHS
-
As goes the U.S, so go the rest of the world! All of us are watching how the pharma pricing scenarios will play out with the U.S. IRA. Check out my colleagues' viewpoints here...
On August 15, 2024, the Centers for Medicare & Medicaid Services (CMS) announced the results of the first round of Medicare drug price negotiations under the Inflation Reduction Act (#IRA). The negotiated prices for 10 selected Part D drugs are expected to yield significant savings, with an estimated $6 billion reduction in net covered prescription drug costs and a 22% lower net spend in aggregate. Most drugs will now be sold at a 65-80% discount off list price. While this announcement provides some clarity on immediate financial impacts, many questions remain about the long-term implications for the pharmaceutical industry, drug development, and patient access to innovative therapies. In their recent #ExecutiveInsights, my colleagues Alex Guth and Adam Nover discuss the announcement and break down both what was clarified and what remains uncertain: https://lnkd.in/dV2x6Tcv #lekconsulting #lek
-
Patient Solution with Celaxis Healthcare * **Patient Education and Support:** CSMOs provide resources and programs to educate patients about their conditions and empower them to manage their health effectively. * **Personalized Patient Experiences:** They leverage technology and data to tailor patient interactions and support based on individual needs and preferences. * **Improved Access to Therapies:** CSMOs connect pharmaceutical companies with healthcare providers, ensuring that patients have access to innovative and effective treatments. * **Enhanced Prescribing Practices:** CSMOs collaborate with medical professionals to optimize prescribing practices, leading to better patient outcomes. * **Bridge Between Pharma and Healthcare:** They facilitate communication and collaboration between pharmaceutical companies and healthcare providers, ensuring that patient needs are met. #RuralMarketing #PatientSolution #patientcare #patientadvocacy #CSMO #ContractSalesAndMarketing #Celaxis #CelaxisHealthcare #pharmaceutical #pharmasolutions #pharmaceuticalindustry
